We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-2.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$58.7B
AUM Growth
-$10.7B
Cap. Flow
-$8.34B
Cap. Flow %
-14.22%
Top 10 Hldgs %
11.75%
Holding
4,329
New
464
Increased
1,327
Reduced
1,794
Closed
713

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.34B
2
TSLA icon
Tesla
TSLA
+$353M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$303M
4
NVDA icon
NVIDIA
NVDA
+$290M
5
BA icon
Boeing
BA
+$286M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 18.47%
3 Consumer Discretionary 12.34%
4 Consumer Staples 10.13%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPIC
2926
DELISTED
TPI Composites
TPIC
$305K ﹤0.01%
115,200
-261,531
-69% -$1.6M
STTK icon
2927
Shattuck Labs
STTK
$704M
$303K ﹤0.01%
199,600
-28,200
-12% -$64.4K
CBIO
2928
Crescent Biopharma
CBIO
$586M
$302K ﹤0.01%
2,011
+850
+73% +$134K
HWC icon
2929
Hancock Whitney
HWC
$6.3B
$302K ﹤0.01%
+8,173
New +$334K
PDS
2930
Precision Drilling
PDS
$963M
$302K ﹤0.01%
4,500
-11,395
-72% -$724K
RWJ icon
2931
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
$302K ﹤0.01%
+8,300
New +$319K
CALF icon
2932
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.77B
$300K ﹤0.01%
7,200
-4,700
-39% -$198K
HRTX icon
2933
Heron Therapeutics
HRTX
$95.5M
$300K ﹤0.01%
291,300
-767,800
-72% -$1.09M
FMBH icon
2934
First Mid Bancshares
FMBH
$1.39B
$297K ﹤0.01%
+11,200
New +$312K
LXRX icon
2935
Lexicon Pharmaceuticals
LXRX
$1.09B
$297K ﹤0.01%
+272,255
New +$478K
UFI icon
2936
UNIFI
UFI
$123M
$297K ﹤0.01%
41,834
-17,047
-29% -$127K
CYT
2937
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$297K ﹤0.01%
104,649
-35,151
-25% -$96.8K
SLQT icon
2938
SelectQuote
SLQT
$122M
$294K ﹤0.01%
251,000
-498,786
-67% -$753K
GHSI
2939
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$293K ﹤0.01%
39,720
+2,100
+6% +$16.2K
GES
2940
DELISTED
Guess Inc
GES
$292K ﹤0.01%
+13,500
New +$285K
GDX icon
2941
VanEck Gold Miners ETF
GDX
$25.5B
$291K ﹤0.01%
10,800
-438,600
-98% -$12.9M
BERZ icon
2942
MicroSectors FANG & Innovation -3x Inverse Leveraged ETN
BERZ
$15.3M
$289K ﹤0.01%
194
+141
+266% +$196K
IDN icon
2943
Intellicheck
IDN
$77.2M
$288K ﹤0.01%
127,816
+35,716
+39% +$89.9K
PLSE icon
2944
Pulse Biosciences
PLSE
$2.62B
$288K ﹤0.01%
+71,500
New +$444K
MTTR
2945
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$288K ﹤0.01%
132,600
-410,100
-76% -$1.15M
DFIV icon
2946
Dimensional International Value ETF
DFIV
$21.5B
$287K ﹤0.01%
8,800
-37,600
-81% -$1.25M
CALB
2947
DELISTED
California BanCorp Common Stock
CALB
$287K ﹤0.01%
14,285
-4,900
-26% -$89.6K
GYRE icon
2948
Gyre Therapeutics
GYRE
$695M
$285K ﹤0.01%
39,379
-12,247
-24% -$82K
SYRE icon
2949
Spyre Therapeutics
SYRE
$9.06B
$285K ﹤0.01%
23,229
+7,509
+48% +$99.3K
VCSA
2950
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$285K ﹤0.01%
30,935
+390
+1% +$4.74K

Similar funds

Renaissance Technologies's Q3 2023 Portfolio in Review

As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.

  • Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
  • Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
  • Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
  • Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
  • Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
  • Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.